Bio-Techne Corporation (TECH)
NASDAQ: TECH · IEX Real-Time Price · USD
75.46
-0.46 (-0.61%)
At close: Jul 19, 2024, 4:00 PM
75.55
+0.09 (0.12%)
Pre-market: Jul 20, 2024, 9:28 AM EDT
Bio-Techne Employees
Bio-Techne had 3,050 employees as of June 30, 2023. The number of employees increased by 50 or 1.67% compared to the previous year.
Employees
3,050
Change (1Y)
50
Growth (1Y)
1.67%
Revenue / Employee
$378,453
Profits / Employee
$66,558
Market Cap
11.89B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Jun 30, 2023 | 3,050 | 50 | 1.67% |
Jun 30, 2022 | 3,000 | 400 | 15.38% |
Jun 30, 2021 | 2,600 | 300 | 13.04% |
Jun 30, 2020 | 2,300 | 50 | 2.22% |
Jun 30, 2019 | 2,250 | 250 | 12.50% |
Jun 30, 2018 | 2,000 | 200 | 11.11% |
Jun 30, 2017 | 1,800 | 240 | 15.38% |
Jun 30, 2016 | 1,560 | 204 | 15.04% |
Jun 30, 2015 | 1,356 | 335 | 32.81% |
Jun 30, 2014 | 1,021 | 167 | 19.56% |
Jun 30, 2013 | 854 | 7 | 0.83% |
Jun 30, 2012 | 847 | 13 | 1.56% |
Jun 30, 2011 | 834 | 97 | 13.16% |
Jun 30, 2010 | 737 | -9 | -1.21% |
Jun 30, 2009 | 746 | 27 | 3.76% |
Jun 30, 2008 | 719 | 38 | 5.58% |
Jun 30, 2007 | 681 | 44 | 6.91% |
Jun 30, 2006 | 637 | 28 | 4.60% |
Jun 30, 2005 | 609 | 12 | 2.01% |
Jun 30, 2004 | 597 | 11 | 1.88% |
Jun 30, 2003 | 586 | 16 | 2.81% |
Jun 30, 2002 | 570 | 9 | 1.60% |
Jun 30, 2001 | 561 | 64 | 12.88% |
Jun 30, 2000 | 497 | 26 | 5.52% |
Jun 30, 1999 | 471 | 60 | 14.60% |
Jun 30, 1998 | 411 | 46 | 12.60% |
Jun 30, 1997 | 365 | -7 | -1.88% |
Jun 30, 1996 | 372 | 28 | 8.14% |
Jun 30, 1995 | 344 | 67 | 24.19% |
Jun 30, 1994 | 277 | 71 | 34.47% |
Jun 30, 1993 | 206 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Fresenius Medical Care AG & Co. KGaA | 119,845 |
Universal Health Services | 96,700 |
DaVita | 70,000 |
Dr. Reddy's Laboratories | 27,048 |
Charles River Laboratories International | 21,800 |
Smith & Nephew | 19,081 |
Catalent | 17,800 |
Legend Biotech | 1,826 |
TECH News
- 7 days ago - BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 7, 2024, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2024 FINANCIAL RESULTS - PRNewsWire
- 7 weeks ago - BIO-TECHNE TO PRESENT AT UPCOMING INVESTOR CONFERENCES - PRNewsWire
- 7 weeks ago - BIO-TECHNE TO HIGHLIGHT MULTIPLE APPLICATIONS OF THE MauriceFlex™ SYSTEM AT THE ANNUAL ASMS CONFERENCE - PRNewsWire
- 7 weeks ago - ScaleReady Announces $20 Million G-Rex® Grant Program for the Advancement of Cell and Gene Therapy (CGT) Development and Manufacturing - PRNewsWire
- 2 months ago - BIO-TECHNE TO PRESENT AT THE 2024 LEERINK PARTNERS HEALTHCARE CROSSROADS CONFERENCE - PRNewsWire
- 2 months ago - BIO-TECHNE HIGHLIGHTS RECENTLY ANNOUNCED TOP-LINE BIOMARKER DATA FROM PARTNER, REGULUS THERAPEUTICS, USING THE COMPANY'S PROPRIETARY TECHNOLOGY - PRNewsWire
- 2 months ago - Court Revokes Two Advanced Cell Diagnostics Patents, Dismisses Infringement Claims Against Molecular Instruments and Orders Advanced Cell Diagnostics to Make Payment of £1.35 Million to Molecular Instruments - Business Wire
- 2 months ago - BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTH CARE CONFERENCE 2024 - PRNewsWire